190 related articles for article (PubMed ID: 26923331)
21. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
[TBL] [Abstract][Full Text] [Related]
22. An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.
Park BH; Kook S; Lee S; Jeong JH; Brufsky A; Lee BC
J Biol Chem; 2013 Oct; 288(40):28656-67. PubMed ID: 23966000
[TBL] [Abstract][Full Text] [Related]
23. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
[TBL] [Abstract][Full Text] [Related]
24. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
25. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
Sengupta S; Schiff R; Katzenellenbogen BS
Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
[TBL] [Abstract][Full Text] [Related]
26. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 and cancer.
Furusato B; Mohamed A; Uhlén M; Rhim JS
Pathol Int; 2010 Jul; 60(7):497-505. PubMed ID: 20594270
[TBL] [Abstract][Full Text] [Related]
28. Pomolic acid inhibits metastasis of HER2 overexpressing breast cancer cells through inactivation of the ERK pathway.
Kim B; Kim YC; Park B
Int J Oncol; 2016 Aug; 49(2):744-52. PubMed ID: 27277173
[TBL] [Abstract][Full Text] [Related]
29. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
[TBL] [Abstract][Full Text] [Related]
30. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
[TBL] [Abstract][Full Text] [Related]
31. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
[TBL] [Abstract][Full Text] [Related]
32. The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.
Gelmini S; Mangoni M; Serio M; Romagnani P; Lazzeri E
J Endocrinol Invest; 2008 Sep; 31(9):809-19. PubMed ID: 18997494
[TBL] [Abstract][Full Text] [Related]
33. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
34. Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.
Li Y; Reader JC; Ma X; Kundu N; Kochel T; Fulton AM
Breast Cancer Res Treat; 2015 Jan; 149(2):403-15. PubMed ID: 25537642
[TBL] [Abstract][Full Text] [Related]
35. Predicting Metastasis from Cues of Metastatic Cancer Stem-like Cells-3D-Ultrasensitive Metasensor at a Single-Cell Level.
Dharmalingam P; Venkatakrishnan K; Tan B
ACS Nano; 2021 Jun; 15(6):9967-9986. PubMed ID: 34081852
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
37. Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Biochim Biophys Acta; 2011 Oct; 1813(10):1767-76. PubMed ID: 21741415
[TBL] [Abstract][Full Text] [Related]
38. The Tissue-Reconstructing Ability of Colon CSCs Is Enhanced by FK506 and Suppressed by GSK3 Inhibition.
Ishida R; Koyanagi-Aoi M; Oshima N; Kakeji Y; Aoi T
Mol Cancer Res; 2017 Oct; 15(10):1455-1466. PubMed ID: 28710230
[TBL] [Abstract][Full Text] [Related]
39. Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).
Wang R; Yang L; Li S; Ye D; Yang L; Liu Q; Zhao Z; Cai Q; Tan J; Li X
Med Sci Monit; 2018 Jan; 24():412-420. PubMed ID: 29353288
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells.
Pan WL; Wang Y; Hao Y; Wong JH; Chan WC; Wan DC; Ng TB
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3837-3846. PubMed ID: 30251699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
